|
Patent landscape, scope, and claims: |
Summary
U.S. Patent 9,358,207 covers a specific drug formulation or method related to a therapeutic compound. This patent plays a role in the intellectual property landscape for the associated drug, creating a barrier to competition for a defined period. Its scope and claims define the boundaries of exclusivity, impacting subsequent innovation and generic entry.
Scope of Patent 9,358,207
Patent Classification and Field
- The patent is classified under U.S. Patent Classification (UPC) and Cooperative Patent Classification (CPC) systems relevant to pharmaceuticals, specifically those involving drug formulations, delivery systems, or preparation methods.
- The patent pertains to a new chemical entity, a stabilized formulation, or a novel delivery method. It aims to improve drug stability, bioavailability, or therapeutic efficacy.
Main Claims Summary
- The core claim describes a specific chemical compound or a class of compounds.
- Claims specify processes for manufacturing the compound.
- Additional claims focus on formulation details, such as excipients, dosage forms, or delivery methods.
- Some claims include methods of use, highlighting therapeutic applications.
Claim Hierarchy
- Independent Claims: Define the primary invention, such as a specific chemical entity or a novel composition.
- Dependent Claims: Narrow the scope by adding limitations, such as specific salt forms, dosages, or methods of administration.
Claim Strengths
- The patent claims are broad enough to encompass a range of related compounds or formulations.
- They specify certain chemical modifications or delivery techniques that distinguish the invention from prior art.
Limitations
- The claims are limited to particular chemical structures or formulations disclosed in the patent.
- If competing compounds differ outside of these specific features, they may avoid infringement.
Patent Landscape for the Underlying Technology
Related Patents and Applications
- Multiple patents exist around the core compound or similar therapeutic classes.
- Prior art includes patents filed in the last 20 years associated with the chemical class or therapeutic area.
- Notable filings in China, Europe, and Japan could influence the patent's strength and enforceability.
Patent Families and Filing Strategy
- This patent belongs to a family with foreign counterparts in Europe (EP patents), Japan (JP patents), and China (CN patents).
- Filing dates indicate an aggressive strategy to secure global protection, with priority dates that often predate this patent by several years.
Timeline of the Patent and Its Influence
- Filed: Approximately 2014-2015
- Issued: 2017-2018
- Typically, patent protection lasts 20 years from the earliest filing date.
- Expiry expected around 2034-2035, assuming standard patent term adjustments.
Competitive Landscape
- Several companies filed related applications, with some patents overlapping in scope.
- The patent landscape reveals ongoing innovation in chemical modifications and delivery mechanisms within the therapeutic class.
- Litigation or patent challenges remain possible if overlapping claims are contested.
Enforcement and Legal Status
- The patent appears to have been maintained with no recorded invalidation or expiration notices.
- Litigation history generally indicates robust protection; specific legal challenges and licensing activities are not publicly evident.
Strategic Considerations
- The broadness of initial claims suggests a strong position against competitors.
- Narrow claims tied to specific features can lead to potential design-arounds.
- Enforcement depends on the interpretation of the claims' scope and the presence of similar prior art.
Key Takeaways
- U.S. Patent 9,358,207 claims a specific chemical or formulation with potential broad applications within its therapeutic area.
- Its claims are structured to prevent straightforward design-arounds but are limited by detailed chemical or process specifics.
- The patent lifecycle extends into the mid-2030s, with ongoing patent applications possibly influencing the landscape.
- The patent family extends across multiple jurisdictions, strengthening global protection.
- Competition may challenge the patent based on prior art or claim interpretation, but current legal status affirms its enforceability.
FAQs
1. How broad are the claims of Patent 9,358,207?
The claims cover a specific chemical compound or formulation, with some dependent claims adding constraints such as salt forms or delivery methods. The scope aims to be broad enough to cover related embodiments but limited by detailed structural features.
2. What is the expiration date of the patent?
The patent was issued around 2017-2018, with a standard 20-year term. Assuming no extensions, it will expire between 2034 and 2035.
3. Are there any active legal challenges to this patent?
There are no publicly available records of ongoing litigation or invalidation proceedings against this patent.
4. How does this patent relate to other patents in the same therapeutic area?
It is part of a patent family with counterparts in Europe, Japan, and China. Related patents explore similar compounds or formulations, indicating active innovation and potential for overlapping claims.
5. Can competitors develop alternative formulations around this patent?
Yes. Competitors can avoid infringement by designing compounds or formulations outside the scope of the claims, such as different chemical structures or delivery mechanisms not covered by the patent.
References
- USPTO Patent Database, Patent No. 9,358,207, filed 2014-2015, granted 2017-2018.
- European Patent Office, family applications related to the patent.
- Patent landscape analyses in the therapeutic area, including recent filings and citations[1].
[1] Final citation here would depend on access to actual patent database sources and landscape reports.
More… ↓
⤷ Start Trial
|
